346 related articles for article (PubMed ID: 8641182)
1. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.
Vitté C; Fleisch H; Guenther HL
Endocrinology; 1996 Jun; 137(6):2324-33. PubMed ID: 8641182
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni M; Guenther HL; Fleisch H; Collin P; Martin TJ
J Clin Invest; 1993 May; 91(5):2004-11. PubMed ID: 8486770
[TBL] [Abstract][Full Text] [Related]
3. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
Fenton AJ; Martin TJ; Nicholson GC
J Cell Physiol; 1993 Apr; 155(1):1-7. PubMed ID: 8468357
[TBL] [Abstract][Full Text] [Related]
4. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.
Yu X; Schøller J; Foged NT
Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139
[TBL] [Abstract][Full Text] [Related]
5. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
Kawaguchi H; Chikazu D; Nakamura K; Kumegawa M; Hakeda Y
J Bone Miner Res; 2000 Mar; 15(3):466-73. PubMed ID: 10750561
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.
Nishikawa M; Akatsu T; Katayama Y; Yasutomo Y; Kado S; Kugal N; Yamamoto M; Nagata N
Bone; 1996 Jan; 18(1):9-14. PubMed ID: 8717530
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.
Van Beek ER; Löwik CW; Papapoulos SE
Bone; 2002 Jan; 30(1):64-70. PubMed ID: 11792566
[TBL] [Abstract][Full Text] [Related]
9. Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.
Schmidt A; Rutledge SJ; Endo N; Opas EE; Tanaka H; Wesolowski G; Leu CT; Huang Z; Ramachandaran C; Rodan SB; Rodan GA
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3068-73. PubMed ID: 8610169
[TBL] [Abstract][Full Text] [Related]
10. Effects of two novel bisphosphonates on bone cells in vitro.
Evans CE; Braidman IP
Bone Miner; 1994 Aug; 26(2):95-107. PubMed ID: 7994190
[TBL] [Abstract][Full Text] [Related]
11. Enhancement by conditioned medium of stretched calvarial bone cells of the osteoclast-like cell formation induced by parathyroid hormone in mouse bone marrow cultures.
Soma S; Matsumoto S; Takano-Yamamoto T
Arch Oral Biol; 1997 Mar; 42(3):205-11. PubMed ID: 9188990
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of osteoclast-stimulating activity by normal clonal osteoblast-like cells: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3.
Collin P; Guenther HL; Fleisch H
Endocrinology; 1992 Sep; 131(3):1181-7. PubMed ID: 1505460
[TBL] [Abstract][Full Text] [Related]
13. The cellular actions of interleukin-11 on bone resorption in vitro.
Hill PA; Tumber A; Papaioannou S; Meikle MC
Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
[TBL] [Abstract][Full Text] [Related]
14. [The biological function of platelet-derived growth factor-BB in the osteoblast-osteoclast co-culture system].
Zhang Z; Chen J; Jin D
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):425-8. PubMed ID: 11798912
[TBL] [Abstract][Full Text] [Related]
15. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
Wei P; Jiao L; Qin LP; Yan F; Han T; Zhang QY
Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364
[TBL] [Abstract][Full Text] [Related]
16. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.
Sato M; Grasser W
J Bone Miner Res; 1990 Jan; 5(1):31-40. PubMed ID: 2106763
[TBL] [Abstract][Full Text] [Related]
17. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
Perez-Amodio S; Beertsen W; Everts V
J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
[TBL] [Abstract][Full Text] [Related]
18. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro.
Qu Q; Härkönen PL; Mönkkönen J; Väänänen HK
Bone; 1999 Aug; 25(2):211-5. PubMed ID: 10456387
[TBL] [Abstract][Full Text] [Related]
19. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
20. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
